Possibility of application of low-frequency piezothromboelastografy method for the evaluation of haemostatic potential of blood in coronary bypass surgery on the background of long aspirinotherapy
https://doi.org/10.20538/1682-0363-2017-3-145-155
Abstract
Aim. To assess the hemostatic system on the aspirin therapy background using the VerifyNow Aspirin test, as well as examining platelet aggregation and low-frequency piezothromboelastography in patients with coronary artery disease during coronary artery bypass grafting.
Materials and methods. 100 people with coronary artery disease who were taking aspirin (75–100 mg daily) for more than 1 year were examined. The study was performed in the perioperative period of coronary bypass surgery without aspirin withdrawal. Evaluation of hemostasis was performed by the VerifyNow Aspirin тest (USA), platelet aggregation (Нelena Laboratories AggRAMTM, Britain) and the low-frequency piezothromboelastography (ARP-01M “Mednord”, Russia).
Results. Patients included in the study were sensitive to aspirin when under long-term administration of a drug: indicator test was VerifyNow ARU 496,9 ± 21,3)%, the platelet aggregation to ADP and adrenaline was reduced by 46% and 52%, respectively. In the early postoperative period platelet aggregation of ADP decreased by 73,2%, collagen – 75,9%, and adrenaline – 82,64% in comparison with the control group.
Perioperative hemorrhagic complications in the study group were not observed. Reduction of platelet aggregation after aspirin therapy was accompanied by an increase in thrombin activity of the blood, which allows for evaluation of the method of low-frequency piezothromboelastography (LPTEG). In the early postoperative period, the results of LPTEG, thrombin potential, and anticoagulant and fibrinolytic activity of blood were partially normalized without reaching the level of the control group.
Conclusion. For the evaluation of hemostasis under aspirin therapy it is advisable to apply the low-frequency piezothromboelastography, which in contrast to the VerifyNow test and traditional platelet aggregation, allows one to reveal a degree of impairment in thrombin blood activity and to conduct an integrative assessment on all aspects of hemostasis.
About the Authors
Elena V. FanaskovaRussian Federation
Head of Cabinet of Ttransfusion Ttherapy; Researcher, Laboratory Hemostasis Research, Research Institute for Complex Issues of Cardiovascular Disease, Kemerovo, Russian Federation.
Olga V. Gruzdeva
Russian Federation
DM, Head of the Laboratory Hemostasis Research, Research Institute for Complex Issues of Cardiovascular Disease; Associate Professor of the Department of Pathophysiology, Medical Clinical Biochemistry, Kemerovo State Medical University, Kemerovo, Russian Federation.
Olga E. Akbasheva
Russian Federation
DM, Professor of the Department of Biochemistry and Molecular Biology, Siberian State Medical University, Tomsk, Russian Federation.
Ivan I. Tyutrin
Russian Federation
DM, Professor of the Department of Anesthesiology and Intensive Care, Siberian State Medical University, Tomsk, Russian Federation.
Tatyana Yu. Penskaya
Russian Federation
Researcher, Laboratory Hemostasis Research, Research Institute for Complex Issues of Cardiovascular Disease, Kemerovo, Russian Federation.
Evgeniya G. Uchasova
Russian Federation
PhD, Researcher, Laboratory Hemostasis Research, Research Institute for Complex Issues of Cardiovascular Disease, Kemerovo, Russian Federation.
Julia A. Dyleva
Russian Federation
PhD, Researcher, Laboratory Hemostasis Research, Research Institute for Complex Issues of Cardiovascular Disease, Kemerovo, Russian Federation.
Olga L. Barbarash
Russian Federation
DМ, Professor, Director of the Research Institute for Complex Issues of Cardiovascular Diseases, Corresponding Member of the Russian Academy of Sciences; Head of the Department of Cardiology and Cardiovascular Surgery, Kemerovo State Medical University, Kemerovo, Russian Federation.
References
1. Bubnova M.G. Aspirin v profilaktike aterotromboza i koronarnoy bolezni serdtsa [Aspirin in the prevention of atherothrombosis and coronary heart disease] // Rossiyskiy kardiologicheskiy zhurnal Russian Journal of Cardiology. 2010; 4 (84): 115–1211 (in Russian).
2. Goldman S., Copeland J., Moritz T., Henderson W., Zadina K., Ovitt T et al. Improvement in saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study // Circulation. 1988; 77: 1324–1332. DOI: 10.1161/01.cir.77.6.1324.
3. Rekomendatsii po lecheniyu stabil’noy ishemicheskoy bolezni serdtsa. ESC 2013 [Recommendations for the treatment of stable coronary heart disease. ESC 2013] // Rossiyskiy kardiologicheskiy zhurnal – Russian Journal of Cardiology. 2014; 7(111): 7–79 (in Russian).
4. Kallis I., Tooze J.A., Talbot S. et al. Pre-operative aspirin decreases platelet aggregation and increases postoperative blood loss-prospective, randomised, placebocontrolled, double-blind clinical trial in 100 patients with chronic stable angina // Eur. J. Cardiothorac. Surg. 1994; 8: 404–409. DOI: 10.1016/1010-7940(94)90081-7/
5. Altarev S.S., Barbarash O.L. Atsetilsalitsilovaya kislota u patsiyentov pered planovymi khirurgicheskimi vmeshatel’stvami [Aspirin in patients prior to elective surgery] // CardioComatika. 2015; 3: 48–57 (in Russian).
6. Charnaya M.A., Dementieva I.I. Ispol’zovaniye aprotinina pri khirurgicheskikh vmeshatel’stvakh, sopryazhennykh s vysokim riskom gemorragicheskikh oslozhneniy [Use of aprotinin in surgical interventions, associated with high risk of bleeding complications] // Khirurgiya. Zhurnal im. N.I. – Pirogova Surgery. Journal of them N.I. Pirogov. 2005; 11: 71–76 (in Russian).
7. Kristensen K.L., Rauer L.J., Mortensen P.E. Kjeldsen BJ. Reoperation for bleeding in cardiac surgery // Inter. Cardiovasc. Thorac. Surg. 2012; 14: 709–713. DOI: 10.1093/icvts/ivs050.
8. Yüksel V., Huseyin S., Canbaz S., Ege T., Sunar H. Emergency reoperation after open heart surgery: ten years of experience // Kardiochirurgia i Torakochirurgia Polska. 2013; 10 (3): 195–198. DOI: 10.5114/kitp.2013.38090.
9. Meybohm P., Zacharowski K., Weber. CF. Point-of-care coagulation management in intensive care medicine // Critical Care. 2013; 17: 218. DOI: 10.1007/978-3-642-35109-9_33.
10. Tyutrin I.I., Udut V.V., Shpisman M.N. Nizkochastotnaya p’yezotromboelastografiya v diagnostike gemostaziologicheskikh rasstroystv: metodicheskoye rukovodstvo [Low-frequency pezotromboelastografiya in the diagnosis of hemostatic disorders: methodical manual]. Tomsk: Mednord–Technology Publ., 2013: 67 (in Russian).
11. Enriquez L.J. and Shore-Lesserson L. Point-of-care coagulation testing and transfusion algorithms // British Journal of Anaesthesia 103 (BJA/PGA Supplement). 2009: 114–122. DOI: 10.1093/bja/aep318
12. Goluhova E.Z., Ryabinin M.N. Sovremennyye aspekty antiagregantnoy terapii [Modern aspects of antiplatelet therapy] // Kreativnaya kardiologiya – Creative cardiology. 2013; 1: 46–58 (in Russian).
13. Kochetkov S.Y. Issledovaniye vliyaniya kombinirovannogo primeneniya atsetilsalitsilovoy kisloty i proizvodnykh 3-gidroksipirina i taurina na nekotoryye pokazateli gemostaza v eksperimente: avtoref. dis. … kand. med. nauk [Investigation of the effect of combined use of acetylsalicylic acid and derivatives of 3-gidroksipirina taurine and some indicators of hemostasis in the experiment: can. dis…]. Saransk, 2015: 145 (in Russian).
14. Lazanyuk V.N., Tarabrin O.A., Bosenko V.I. Diagnostika i kompleksnaya korrektsiya gemorragicheskikh rasstroystv u detey, operirovannykh po povodu tsianoticheskikh vrozhdennykh porokov serdtsa [Diagnosis and comprehensive correction of hemorrhagic disorders in children undergoing surgery for cyanotic congenital heart disease] // Kompleksnyye problemy serdechno-sosudistykh zabolevaniy – Complex problems cardiovascular diseases. 2016; 1: 60–70 (in Russian). DOI: 10.17802/2306-1278-2016-1-60-70.
Review
For citations:
Fanaskova E.V., Gruzdeva O.V., Akbasheva O.E., Tyutrin I.I., Penskaya T.Yu., Uchasova E.G., Dyleva J.A., Barbarash O.L. Possibility of application of low-frequency piezothromboelastografy method for the evaluation of haemostatic potential of blood in coronary bypass surgery on the background of long aspirinotherapy. Bulletin of Siberian Medicine. 2017;16(3):145-155. (In Russ.) https://doi.org/10.20538/1682-0363-2017-3-145-155